Ірина Драпак
Ірина Драпак
професор, доктор фармацевтичних наук, Львівський національний медичний університет імені Данила
Підтверджена електронна адреса в meduniv.lviv.ua
Назва
Посилання
Посилання
Рік
Synthesis of Some Novel Thiazolo (4, 5-b) Pyridinesand their Tuberculostatic Activity Evaluation
T Chaban, O Klenina, I Drapak, V Ogurtsov, I Chaban, V Novikov
Chemistry & Chemical Technology, 287-292, 2014
262014
QSAR studies of some thiazolo [4, 5-b] pyridines as novel antioxidant agents: enhancement of activity by some molecular structure parameters
O Klenina, I Drapak, T Chaban, V Ogurtsov, I Chaban, I Golos
Publishing House of Lviv Polytechnic National University, 2013
262013
Synthesis of 2-(4-aryl (adamantyl)-2-phenylіmіnothіazol-3-yl)-ethanol derivatives and prediction of their biological activity
HO Yeromina, IV Drapak, LO Perekhoda, VD Yaremenko, ...
Der Pharma Chemica, 2016
152016
Polymer films with size-selected silver nanoparticles as plasmon resonance-based transducers for protein sensing
H Muhammad, RR Juluri, P Fojan, V Popok
Biointerface Research in Applied Chemistry 6 (5), 1564-1568, 2016
132016
Cardiovascular calcium channel blockers: historical overview, development and new approaches in design
I Drapak, L Perekhoda, T Tsapko, N Berezniakova, Y Tsapko
Journal of Heterocyclic Chemistry 54 (4), 2117-2128, 2017
122017
Synthesis, antimicrobial and antitumor activities of 2-[5-(2-R-benzyl) thiazol-2-ylimino] thiazolidin-4-ones
I Drapak, V Foliush, T Chaban, V Matiychuk
Biointerface Res Appl Chem 10 (3), 5507-11, 2020
92020
Synthesis and in silico research of derivatives of 3-allyl-4-(R-phenyl)-N-(R1-phenyl) thiazole-2-imine
LO Perekhoda, MM Suleiman, IA Sych, VD Yaremenko, IV Drapak
92017
The antioxidant properties of 1-[2-(R-phenylimino)-4-methyl-3-(3-[morpholine-4yl] propyl)-2, 3-dihydro-1, 3-thiazol-5-yl] ethane-1-one derivatives under conditions of …
LO Perekhoda, NP Kobzar, HO Yeromina, IV Drapak
92017
The use of the docking studies with the purpose of searching potential cardioprotectors
IV Drapak, LO Perekhoda, O Vynogradova, M Protopopov, MM Suleiman, ...
72018
A review on synthetic routes for obtaining of 2, 5-disubstituted 1, 3, 4-oxadiazoles via cyclodehydration and oxidative cyclization reactions
M Lelyukh, I Demchuk, S Harkov, T Chaban, I Drapak, I Chaban, ...
Biointerface Research in Applied Chemistry 10, 5960-5971, 2020
62020
HPLC method development for the analysis of bisoprolol in combined dosage form containing bisoprolol and enalapril and in vitro dissolution studied
L Logoyda, S Kovalenko, AM AbdelMegied, I Zhulkevych, I Drapak, ...
International Journal of Applied Pharmaceutics 11 (3), 186-194, 2019
62019
Search for Biologically Active Substances with Antimicrobial and Antifungal Action in the series of 2.5-disubstituted 1, 3, 4-tiadiazoles
IV Sych, IV Drapak, MM Suleiman, MV Rakhimova, NP Kobzar, IA Sych, ...
Research Journal of Pharmacy and Technology 12 (6), 2871-2876, 2019
62019
Cardioprotective activity of some 2-arylimino-1, 3-thiazole derivatives
I Drapak, L Perekhoda, N Demchenko, M Suleiman, M Rakhimova, ...
Scientia Pharmaceutica 87 (1), 7, 2019
52019
The synthesis and physicochemical properties of new derivatives of 5-r-phenylamino-2-mercapto-1, 3, 4-thiadiazole
IV Sych, LO Perekhoda, ZG Ieromina, LO Grinevich, NP Kobzar, ...
News of Pharmacy, 24-28, 2016
52016
Synthesis of some С5 substituted 4-phenylimino-thiazolidin-2-ones as possible anti-inflammatory agents
Z Сhulovska, T Chaban, I Drapak, V Matiychuk, I Chaban, I Nektegaev
Biointerface Research in Applied Chemistry 11, 8009-8017, 2021
42021
Historical overview, development and new approaches in design of angiotensin converting enzyme inhibitors and angiotensin receptor antagonists Part IІ
IV Drapak, NL Bereznyakova, OV Kiz, LO Perekhoda, TO Tsapko
42017
Approaches for synthesis and chemical modification of non-condensed heterocyclic systems based on 1, 3, 4-oxadiazole ring and their biological activity: A review
M Lelyukh, M Martynets, M Kalytovska, I Drapak, S Harkov, T Chaban, ...
Journal of Applied Pharmaceutical Science 10 (10), 151-165, 2020
32020
Development of assay method for analysis of a novel Kardiazol substance by HPLC
I Drapak, I Bezruk, L Ivanauskas
Lietuvos farmacijos žinios= Lithuanian Pharmaceutical News: XXII Tarptautinė …, 2019
32019
The use of the docking studies with the purpose of searching Potential Antihypertensive Drugs
I Drapak, M Suleiman, M Protopopov, H Yeromina, I Sych, Z Ieromina, ...
Research Journal of Pharmacy and Technology 12 (10), 4889-4894, 2019
32019
QSAR-analysis of 1-[2-(R-phenylimino)-4-methyl-3-(3-[morpholine-4-yl] propyl)-2, 3-dihydro-1, 3-thiazol-5-yl] ethane-1-one's derivatives as potential antioxidants
IV Drapak, BS Zimenkovsky, LO Perekhoda, HO Yeromina, K Lipakova, ...
32019
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20